Results 261 to 270 of about 63,749 (300)

Hs-CRP in early childhood wheezing

7.2 Paediatric Asthma and Allergy, 2016
Introduction: High-sensitivity C -reactive protein (hs-CRP) is a biomarker reflecting low-grade systemic inflammation, but its role among wheezing infants is still unknown. Objective: To demonstrate, whether hs-CRP has any association with recurrent wheezing, atopic markers, baseline lung function, or airway responsiveness in infants with ...
Määttä, Anette, Kotaniemi-Syrjänen, Anne, Malmström, Kristiina, L. Pekka Malmberg, Pelkonen, Anna S., Mäkelä, Mika J.   +5 more
openaire   +1 more source

Prognostic value of suPAR and hs-CRP on cardiovascular disease

Atherosclerosis, 2018
Studies have shown that soluble urokinase Plasminogen Activator Receptor (suPAR) and CRP (both inflammatory markers) and coronary artery calcification (CAC) are independent risk predictors for cardiovascular (CV) disease. The aim of this study is to assess whether suPAR and CRP have an increased predictive prognostic value beyond the traditional CV ...
Marie Zöga Diederichsen, Søren Zöga Diederichsen, Hans Mickley, Flemming Hald Steffensen, Jess Lambrechtsen, Niels Peter Rønnow Sand, Kent Lodberg Christensen, Michael Hecht Olsen, Axel Diederichsen, Mette Hjortdal Grønhøj   +9 more
openaire   +3 more sources

STUDY OF HS-CRP IN PEOPLE OF HUE CITY

Journal of Medicine and Pharmacy, 2015
Background: High sensitivity C reactive protein is a protein that occur in acute phase of inflammation. hs-CRP is considered as a predict factor of cardiovascular and cerebrovascular risk. Framingham risk score is a strong predictor of cardiovascular and cerebrovascular risk and death. In Viet Nam there was still few studies about hs-CRP and Framingham
Anh Tien Hoang, Kim Phuong Le
openaire   +1 more source

Baseline hs‐CRP predicts hypertension remission in metabolic syndrome

European Journal of Clinical Investigation, 2019
AbstractBackgroundInflammation, overweight and other cardiovascular risk factors might negatively impact on hypertension remission in metabolic syndrome (MetS), independently of the pharmacological treatment. Here, the potential influence of systemic inflammation (assessed by serum high‐sensitivity C‐reactive protein [hs‐CRP]) on hypertension remission
Carbone, F, Elia, E, Casula, M, Bonaventura, A, Liberale, L, Bertolotto, M, Artom, N, Minetti, S, Dallegri, F, Contini, P, Verzola, D, Pontremoli, R, Viazzi, F, L Viviani, G, Bertolini, S, Pende, A, Pisciotta, L, Montecucco, F   +17 more
openaire   +4 more sources

Evaluation of fluorescence hs-CRP immunoassay for point-of-care testing

Clinica Chimica Acta, 2005
C-reactive protein (CRP) is one of acute phase respondents that has been used to monitor infection and inflammation episodes. Recent studies have shown that high-sensitivity C-reactive protein (hs-CRP) is a potential risk predictor for future atherosclerosis and cardiovascular diseases (CVD).We previously developed a fluorescence-based ...
Sang Wook, Oh, Jung Dae, Moon, Sang Yeol, Park, Heuk Jae, Jang, Jae Hoon, Kim, Ki Bong, Nahm, Eui Yul, Choi   +6 more
openaire   +2 more sources

[HS CRP with Fumouze immunoturbidimetry and Dade Behring immunonephelemetry].

Annales de biologie clinique, 2006
Increased concentrations of high sensitivity C-reactive protein are associated with increased risk for coronary heart disease. We report here a comparison of Fumouze hs-CRP turbidimetric method on Roche Diagnostics Hitachi 911 with Dade Behring BN II nephelemetric method. 134 samples were analysed.
B, Onraed, B, Hennache
openaire   +2 more sources

A study of Hs-CRP and lipid profile in overweight individuals

International Journal of Medical Science and Public Health, 2013
Background: Obesity and overweight are widespread phenomena. Dyslipidaemia observed in obese people is an important risk factor for coronary heart disease. Levels of obesity have been shown to be associated with low-grade inflammation and C-reactive protein, an inflammatory marker has been associated with the presence and severity of atherosclerosis.
H Reddy, B Laxmikanth, P Sujatha, Prabhavati Modi   +3 more
openaire   +1 more source

New risk markers beyond lipids and hs-CRP

Pathology, 2010
The extent to which the classical cardiovascular disease (CVD) risk factors can predict clinical events is a matter of debate. Hundreds of novel risk factors have been nominated and any that play a causative role would offer the possibility of treatment innovation.
David Sullivan, Alicia Jenkins, Tony Keech   +2 more
openaire   +1 more source

Correlation of salusin beta with hs-CRP and ADMA in hypertensive children and adolescents

Atherosclerosis, 2018
Purpose: The emerging evidence has recently shown an evident dependence between recently identified salusin peptides and atherosclerosis, and their important roles as endogenous modulators of atherogenesis. It was reported that the development of atherosclerosis could also be affected by endogenous salusin- β overproduction in vascular lesions ...
Urszula, Kołakowska, Elżbieta, Kuroczycka-Saniutycz, Witold, Olański, Anna, Wasilewska   +3 more
openaire   +2 more sources

[Significances of NT-proBNP and hs-CRP in heart failure].

Zhonghua yi xue za zhi, 2011
To detect the level changes of plasma N-terminal B-type natriuretic peptide (NT-proBNP) and high-sensitivity C-reactive protein (hs-CRP) in patients with heart failure (HF) and explore their clinical correlations and prognostic significances.A total of 100 cases of HF patients were selected along with 20 age and gender-matched controls.
Li, Wang, Shan-You, Hu, Xiao, Wu, Xue-Feng, Jü   +3 more
openaire   +1 more source